Reply to a letter to the editor: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
Graefes Arch Clin Exp Ophthalmol
.
2017 Feb;255(2):429-430.
doi: 10.1007/s00417-016-3560-2.
Epub 2016 Dec 13.
Authors
Nicole Eter
1
,
Andreas Mohr
2
,
Joachim Wachtlin
3
,
Nicolas Feltgen
4
Affiliations
1
University of Münster Medical School, Münster, Germany. eter@uni-muenster.de.
2
Eye Hospital St. Joseph-Stift, Bremen, Germany.
3
Augenabteilung, Sankt Gertrauden Krankenhaus, Berlin, Germany.
4
University Eye Care Hospital, Göttingen, Germany.
PMID:
27957601
DOI:
10.1007/s00417-016-3560-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Dexamethasone
Drug Implants
Glucocorticoids*
Humans
Intravitreal Injections
Macular Edema
Prospective Studies
Retinal Vein Occlusion*
Visual Acuity
Substances
Drug Implants
Glucocorticoids
Dexamethasone